Hyperbaric Oxygen Therapy for Acute Ischemic Stroke

Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930)

Recruiting N/A Interventional Study
Acute Ischemic Stroke
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
120 (estimated)
Sponsor
LCMC Health · Other
Who this trial is looking for

This trial is looking for adults who have had an ischemic stroke and are currently in inpatient rehabilitation. Participants will receive hyperbaric oxygen therapy to help improve their recovery.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am 18 years or older
  • I have had an ischemic stroke confirmed by imaging
  • It has been 7 to 30 days since my stroke
  • I am admitted to Touro Inpatient Rehab Facility

You may not be able to join if

  • My pre-stroke modified Rankin Scale Score is over 2
  • I have experienced parenchymal hemorrhagic transformation
  • I have receptive aphasia that prevents me from following safety instructions
  • I have a history of recurrent seizures that changed my treatment in the past 3 months
  • I have a lung disease that requires supplemental oxygen or daily respiratory medications

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

This study will critically examine the feasibility, safety and efficacy of HBOT during inpatient rehabilitation (IPR) after acute ischemic stroke measured by non-disruption of 3 hours of daily therapy, frequency of neurological deterioration or complications (seizure, hemorrhage, brain edema), and functional communication, activities of daily living (ADLs) and mobility.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age 18 years and above * Ischemic stroke proven on neuroimaging * Within 7-30 days post-stroke on day 1 of treatment * Admitted to Touro Inpatient Rehab Facility Exclusion Criteria: * Pre-stroke modified Rankin Scale Score \>2 * Parenchymal hemorrhagic transformation (PH1 or…
Contacts

Lawrence Matarutse

504-962-6419

Lawrence.Matarutse@lcmchealth.org

CONTACT

Sheryl Martin-Schild, MD, PhD

504-982-3278

sheryl.martin-schild@lcmchealth.org

CONTACT